期刊文献+

肺结核患者全血γ干扰素释放试验影响因素的探讨

Study on the Influencing Factors of Whole Blood Gamma Release Assay in the Patients with Pulmonary Tuberculosis
下载PDF
导出
摘要 目的探讨菌量负荷、疾病活动性、影像学累及范围、外周血淋巴细胞计数等因素对全血γ干扰素释放试验结果的影响。方法选取肺结核患者106例(包括44例菌阳肺结核患者、47例菌阴肺结核患者和15例陈旧性肺结核患者)和健康对照组35名,所有患者(健康对照者)抽取外周血并以肝素抗凝分别与结核分枝杆菌特异抗原分泌抗原靶-6(ESAT-6)、ESAT-6/培养滤过蛋白-10(CFP-10)融合抗原、PPD共同孵育,并用ELISA的方法检测血浆中IFN-γ的含量,各组间差异的比较应用Mann-WhitneyU检验,P〈0.05为差异有统计学意义。结果抗原刺激后分泌IFN—γ量的中位数在菌阳组和菌阴组之间差异无统计学意义[ESAT-6(114.7Pg/ml vs 82Pg/ml,Z=-0.500,P〉0.05),ESAT-6/CFP-10(3488Pg/mlvs 2350Pg/ml,Z=-0.949,P〉0.05),PPD(4514Pg/mlvs4326Pg/ml,Z=-0.822,P〉0.05)];ESAT-6和ESAT-6/CFP-10抗原刺激后分泌IFN-γ量的中位数在菌阴组和陈旧性肺结核组之间差异无统计学意义[ESAT-6(82Pg/mlvs137Pg/ml,Z=-0.781,P〉0.05),ESAT-6/CFP-10(2350Pg/mlvs1784Pg/ml,Z=-1.685,P〉0.05)],ESAT-6抗原刺激后分泌IFN—γ量的中位数在菌阳组和陈旧性肺结核组之间差异无统计学意义(114.7Pg/mlvs137Pg/ml,Z=-0.757,P〉0.05),但ESAT-6/CFP-10融合抗原刺激后分泌IFN-γ量的中位数在菌阳组和陈旧性肺结核组之间差异有统计学意义(3488Pg/mlvs1784Pg/ml,z=-0.242,P〈0.05);ESAT-6、EsAT-6/CFP-10融合抗原刺激后分泌IFN—γ量的中位数在肺部病变累及少和肺部病变累及多之间差异有统计学意义[ESAT-6(117Pg/mlvs42Pg/ml,z=-2.341,P〈0.05),ESAT-6/CFP-10(3055Pg/mlvs1562.5Pg/ml,Z=-2.850,P〈0.05)];ESAT-6、ESAT-6/CFP-10融合抗原、PPD抗原刺激后分泌IFN—γ量的中位数在外周血淋巴细胞≥1.0×10^9/L和〈1.0×10^9/L之间差异有统计学意义[ESAT-6(97.5Pg/mlvs48Pg/ml,Z=-2.745,P〈0.05),ESAT-6/CFP-10(3082Pg/mlvs1190Pg/ml,z=-2.911,P〈0.05),PPD(4322Pg/mlvs3200Pg/ml,z=-2.216,P〈0.05)]。结论基于RDl区的抗原刺激后外周血分泌IFN-γ的量不受菌量负荷的影响,但可能受到外周血淋巴细胞绝对值和病变累及范围的影响。 Objective To evaluate the clinical influencing factors on the whole blood gamma release assay in the patients with pulmonary tuberculosis. Methods One hundred and six clinical diagnosed tuberculosis patients who included 44 smear-or culture-positive cases, 47 smear-or culture-negative cases and 15 cases with non-active pulmonary tuberculosis and 35 healthy controls were enrolled in this study. The heparinized bloods from all participants were incubated with purified protein derivative (PPD) and M. tuberculosis-specific antigens early secretory antigen target 6 ( ESAT- 6) and ESAT-6/CFP-10 fusion protein encoded in the mycobacterial genomic region of difference (RD1) . The production of interferon γ ( IFN- γ ) was detected with ELISA. Results There were no significant difference between smear-positive group and smear-negative group in the IFN- γ median stimulated by ESAT-6 ( 114. 7 pg/ml vs 82 pg/ml, Z = - 0. 500, P 〉 0. 05) , ESAT-6/CFP-10 ( 3488 pg/ml vs 2350 pg/ml, Z = - 0. 949,P 〉 0. 05) and PPD ( 4514 pg/ml vs 4326 pg/ml, Z= - 0. 822, P 〉 0. 05) . The IFN- γ median stimulated by ESAT-6 ( 82 pg/ml vs 137 pg/ml, Z = - 0. 781, P 〉0. 05) and ESAT-6/CFP-10 ( 2350 pg/ml vs 1784 pg/ml, Z = - 1. 685, P 〉 0.05) had not significant difference between the smear negtive pulmonary tuberculosis group and non-active pulmonary tuberculosis group. However, there were statistic difference between smear-positive pulmonary tuberculosis group and non-active pulmonary tuberculosis group in the IFN- γ median stimulated by ESAT-6/CFP-10( 3488 pg/ml vs 1784 pg /ml, Z = - 0. 242, P 〈 0. 05) . The patients with less than 4 segments of lesions on the X-ray had higher IFN- γ, median than those with more than 4segmentsoflesions [ESAT-6(117pg/mlvs42pg/ml, Z= - 2. 341, P 〈 0.05) , ESAT-6/CFP-10(3055pg/mlvs 1562.5pg/ml, Z = - 2. 850, P 〈 0. 05) ]. There were also significant difference between the patients with higher peripheral blood lymphocyte count ( ≥ 1.0 × 10^9/L) and those with lower peripheral blood lymphocyte count ( 〈 1.0 × 10^9/L) in the IFN-γ median [ESAT-6 ( 97.5 pg/ml vs 48 pg/ml, Z= - 2. 745, P 〈 0. 05), ESAT-6/CFP-10 ( 3082 pg/ml vs 1190 pg/rnl, Z = - 2. 911, P 〈 0. 05), PPD( 4322 pg/ml vs 3200 pg/ml, Z = - 2. 216, P 〈 0.05) ]. Conclusion The production oflFN- γ, stimulated by M. tuberculosis specific antigens was not influenced by the load of bacilli, and probably influenced by accumulated lesion in X-ray and peripheral blood lymphocyte count.
出处 《结核病与胸部肿瘤》 2014年第2期84-89,共6页 Tuberculosis and Thoracic Tumor
基金 首都医学发展科研基金(20093147)
关键词 结核 诊断 Γ干扰素释放试验 Tuberculosis, pulmonary/diagnosis Interferon-gamma release tests
  • 相关文献

参考文献16

  • 1Elhay MJ, Oettinger T, Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect lmmun, 1998, 66(7) : 3454-3456.
  • 2Dillon DC, Alderson MR, Day CH, et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol, 2000, 38 (9) : 3285-3290.
  • 3熊勇超,侯月云,赵建忠,郭晖,何广学.γ干扰素释放试验在检测结核分枝杆菌潜伏感染中的应用[J].中国防痨杂志,2012,34(9):613-616. 被引量:31
  • 4Brock I, Weldingh K, Lillebaek T, et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med, 2004, 170 (1) : 65-69.
  • 5Ewer K, Decks J, Alvarez L, et al. Comparison of T-cell-based tuberculosis infection in a school tuberculosis outbreak. Lancet, 2003, 361 (9364) : 1168-1173.
  • 6Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracingand spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet, 2001, 357 (9273) : 2017-2021.
  • 7杨新婷,贾红彦,李琦,卜建玲,古淑香,杜凤娇,张宗德,陈效友.全血γ干扰素释放试验在菌阴肺结核中诊断价值的临床观察[J].中国临床医生杂志,2013,41(3):42-45. 被引量:27
  • 8曾谊,冯枭,宋梅梅,林云霞,费贤树,袁广琴.酶联免疫斑点试验在菌阴肺结核诊断中的价值[J].中国防痨杂志,2012,34(2):100-102. 被引量:35
  • 9Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med, 2007, 146 (5): 340-354.
  • 10Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis, 2007, 44 (1) : 69-73.

二级参考文献38

  • 1谢莉,马玙,高微微,李传友,张宗德,陈效友,古书香,邢爱英,郑素华,刘忠泉,陈曦,韩喜琴.抗原刺激后外周血单个核细胞γ干扰素释放反应在结核分枝杆菌感染和结核病诊断中的意义[J].中华结核和呼吸杂志,2005,28(8):545-549. 被引量:13
  • 2肖和平.菌阴肺结核在结核病控制中的重要性[J].中华结核和呼吸杂志,2005,28(10):665-666. 被引量:87
  • 3O. Oxlade,K. Schwartzman,D. Menzies,张宗德(译),杨振旦(校),张立兴(审).在高收入国家的γ干扰素释放试验与结核病筛查:成本-效益分析[J].国际结核病与肺部疾病杂志,2007,2(1):17-29. 被引量:5
  • 4Lalvani A. Diagnosing tuberculosis infection in the 21st century [J]. Chest, 2007,13](6) :1898--1906.
  • 5Doherty, T.M. Immune responses to the Mycobacterium tuber culosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients [J]. Clin Microbiol 2002,40(2) : 704 -- 706.
  • 6Herrmann JL, Simonney N, Bergeron A,et al. Pathologie-Biologie(Paris)[M]. 2008 Apr 3. PMID.. 18395363.
  • 7Alton B, Farris MD, John A, Branda MD. QuantiFERON-TB gold assay for tuberculosis infection. Clinical Microbiology Newsletter, 2007,131 : 1--27.
  • 8Naseer A, Naqvi S, Kampmann B. Evidence for boosting Myco- bacterium tuberculosis-specific IFN-gamma responses at 6 weeks folloWing tuberculin skin testing[J]. Eur Respir J 2007,29(6): 1282-1283.
  • 9Richeldi L, Ewer K, Losi M. Repeated tuberculin testing does not induce false positive ELISPOT results[J]. Thorax, 2006, 61:180.
  • 10Gerald H. Mazurek, MD, John Jereb, MD, Andrew Vernon, MD, Phillip LoBue, MD, Stefan Goldberg, MD, Kenneth Castro, MD, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, CDC. Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection-United States, 2010[J]. MMWR, 2010:1--28.

共引文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部